<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1491" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1491/" /><meta name="ncbi_pagename" content="DRPLA - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>DRPLA - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="DRPLA" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/06/09" /><meta name="citation_author" content="Liana Veneziano" /><meta name="citation_author" content="Marina Frontali" /><meta name="citation_pmid" content="20301664" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1491/" /><meta name="citation_keywords" content="Dentatorubral-Pallidoluysian Atrophy" /><meta name="citation_keywords" content="Dentatorubral-Pallidoluysian Atrophy" /><meta name="citation_keywords" content="Atrophin-1" /><meta name="citation_keywords" content="ATN1" /><meta name="citation_keywords" content="DRPLA" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="DRPLA" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Liana Veneziano" /><meta name="DC.Contributor" content="Marina Frontali" /><meta name="DC.Date" content="2016/06/09" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1491/" /><meta name="description" content="Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive disorder of ataxia, myoclonus, epilepsy, and progressive intellectual deterioration in children and ataxia, choreoathetosis, and dementia or character changes in adults. Onset ranges from before age one year to age 72 years; mean age of onset is 31.5 years. The clinical presentation varies depending on the age of onset. The cardinal features in adults are ataxia, choreoathetosis, and dementia. Cardinal features in children are progressive intellectual deterioration, behavioral changes, myoclonus, and epilepsy." /><meta name="og:title" content="DRPLA" /><meta name="og:type" content="book" /><meta name="og:description" content="Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive disorder of ataxia, myoclonus, epilepsy, and progressive intellectual deterioration in children and ataxia, choreoathetosis, and dementia or character changes in adults. Onset ranges from before age one year to age 72 years; mean age of onset is 31.5 years. The clinical presentation varies depending on the age of onset. The cardinal features in adults are ataxia, choreoathetosis, and dementia. Cardinal features in children are progressive intellectual deterioration, behavioral changes, myoclonus, and epilepsy." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1491/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/drpla/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1491/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D0441E03FA2110000000006ED027C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1491_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1491_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/dnmt1-ddsn/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/dyrk1a-id/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1491_"><span class="title" itemprop="name">DRPLA</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Dentatorubral-Pallidoluysian Atrophy</div><p class="contrib-group"><span itemprop="author">Liana Veneziano</span>, PhD and <span itemprop="author">Marina Frontali</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1491_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1491_ai__"><div class="contrib half_rhythm"><span itemprop="author">Liana Veneziano</span>, PhD<div class="affiliation small">Institute of Translational Pharmacology<br />Italian National Research Council (CNR)<br />Rome, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.rnc.tfi@onaizenev.anail" class="oemail">ti.rnc.tfi@onaizenev.anail</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Marina Frontali</span>, MD<div class="affiliation small">Institute of Translational Pharmacology<br />Italian National Research Council (CNR)<br />Rome, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.rnc.tfi@ilatnorf.aniram" class="oemail">ti.rnc.tfi@ilatnorf.aniram</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 6, 1999</span>; Last Update: <span itemprop="dateModified">June 9, 2016</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="drpla.Summary" itemprop="description"><h2 id="_drpla_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive disorder of ataxia, myoclonus, epilepsy, and progressive intellectual deterioration in children and ataxia, choreoathetosis, and dementia or character changes in adults. Onset ranges from before age one year to age 72 years; mean age of onset is 31.5 years. The clinical presentation varies depending on the age of onset. The cardinal features in adults are ataxia, choreoathetosis, and dementia. Cardinal features in children are progressive intellectual deterioration, behavioral changes, myoclonus, and epilepsy.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of DRPLA is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical findings and a family history of DRPLA or by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic CAG trinucleotide expansion in <i>ATN1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. The CAG repeat length in individuals with DRPLA ranges from 48 to 93.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Standard antiepileptic drugs (AEDs) for seizures; appropriate psychotropic medications for psychiatric manifestations; symptomatic treatment of ataxia with riluzole and rehabilitation therapy; adaptation of environment and care to the level of dementia; appropriate educational programs for children.</p><p><i>Agents/circumstances to avoid.</i> General anesthesia can increase the risk of intra- and postoperative seizures.</p><p><i>Pregnancy management.</i> The use of antiepileptic medication during pregnancy may have an effect on the fetus. Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception; transition to a lower-risk medication may be possible. The use of riluzole during pregnancy has not been well studied in humans.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>DRPLA is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The risk to the offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual of inheriting an expanded CAG repeat is 50%. The size of the repeat transmitted to the offspring depends on the size of the parent's repeat and the gender of the transmitting parent. Prenatal testing for pregnancies at increased risk is possible using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the diagnosis in the family has been confirmed.</p></div></div><div id="drpla.Diagnosis"><h2 id="_drpla_Diagnosis_">Diagnosis</h2><p>No formal clinical diagnostic criteria are available for DRPLA.</p><div id="drpla.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Dentatorubral-pallidoluysian atrophy (DRPLA) <b>should be suspected</b> in individuals with the following clinical features (by age), brain MRI findings, and family history:</p><ul><li class="half_rhythm"><div><b>Clinical features (by age)</b></div><ul><li class="half_rhythm"><div><b>Age &#x0003c;20 years.</b> Ataxia, myoclonus, seizures, progressive intellectual deterioration</div></li><li class="half_rhythm"><div><b>Age &#x0003e;20 years.</b> Ataxia, choreoathetosis, dementia, psychiatric disturbance</div></li></ul></li><li class="half_rhythm"><div><b>Brain MRI findings.</b> Cerebellar and brain stem atrophy [<a class="bk_pop" href="#drpla.REF.tsuji.2012.587">Tsuji 2012</a>]</div></li><li class="half_rhythm"><div><b>Family history.</b> Consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance and Asiatic (mainly Japanese) <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> origin</div></li></ul><p>Note: (1) Absence of a family history of DRPLA does not preclude the diagnosis. (2) DRPLA is extremely rare outside of Asiatic populations [<a class="bk_pop" href="#drpla.REF.tsuji.2012.587">Tsuji 2012</a>].</p></div><div id="drpla.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of DRPLA <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical findings and a family history of DRPLA <b>or</b> by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic CAG trinucleotide expansion in <i>ATN1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1491/table/drpla.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figdrplaTmoleculargenetictestingusedi" rid-ob="figobdrplaTmoleculargenetictestingusedi">Table 1</a>).</p><p>Note: Comprehensive testing strategies for the diagnosis of ataxic disorders can be found in <a class="bk_pop" href="#drpla.REF.van_de_warrenburg.2014.552">van de Warrenburg et al [2014]</a> and the <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>.</p><p><b>Allele sizes</b></p><ul><li class="half_rhythm"><div>Normal alleles: 6-35 CAG repeats</div></li><li class="half_rhythm"><div>Mutable normal alleles: Mutable normal alleles are not associated with symptoms but are unstable and can expand on transmission resulting in occurrence of symptoms in the next generation; this is a very rare event. The normal Japanese population has a greater number of individuals with 20-35 CAG repeats than are found in populations of European origin [<a class="bk_pop" href="#drpla.REF.takano.1998.1060">Takano et al 1998</a>].</div></li><li class="half_rhythm"><div>Full-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> alleles: &#x02265;48 CAG repeats. The largest <a class="def" href="/books/n/gene/glossary/def-item/full-penetrance-allele/">full-penetrance allele</a> reported to date is 93 [<a class="bk_pop" href="#drpla.REF.shimojo.2001.277">Shimojo et al 2001</a>, <a class="bk_pop" href="#drpla.REF.maruyama.2012.2329">Maruyama et al 2012</a>].</div></li></ul><p>Molecular testing approaches typically involve <b>targeted testing</b>. Testing is typically performed by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> amplification of the <i>ATN1</i> <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> region followed by gel or capillary electrophoresis.</p><p>Note: (1) In CAG repeat disorders in general, highly expanded alleles (usually &#x0003e;100 CAG repeats) may not be detectable by the <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a>-based assay, and additional testing (e.g., <a class="def" href="/books/n/gene/glossary/def-item/southern-blot/">Southern blot</a> analysis or triplet repeat primed [TP] PCR [<a class="bk_pop" href="#drpla.REF.warner.1996.1022">Warner et al 1996</a>]) is indicated to detect a highly expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in individuals who are apparently homozygotes by PCR analysis. (2) Variants detectable by sequencing analysis have not been associated with DRPLA.</p><div id="drpla.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in DRPLA</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1491/table/drpla.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__drpla.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_drpla.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_drpla.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_drpla.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_drpla.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATN1</i></td><td headers="hd_h_drpla.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_drpla.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="drpla.TF.1.1"><p class="no_margin">See <a href="/books/NBK1491/#drpla.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="drpla.TF.1.2"><p class="no_margin">See <a href="#drpla.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd></dl></div></div></div></div></div><div id="drpla.Clinical_Characteristics"><h2 id="_drpla_Clinical_Characteristics_">Clinical Characteristics</h2><div id="drpla.Clinical_Description"><h3>Clinical Description</h3><p>Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive disorder of ataxia, myoclonus, epilepsy, and progressive intellectual deterioration in children and ataxia, choreoathetosis, and dementia or character changes in adults. The onset of DRPLA ranges from infancy to late adulthood (range: 0-72 years; mean: 31.5 years) [<a class="bk_pop" href="#drpla.REF.hasegawa.2010.1694">Hasegawa et al 2010</a>]. Disease duration is on average eight years (range 0-35 years) and age at death is on average 49 years (range 18-80 years) [<a class="bk_pop" href="#drpla.REF.hasegawa.2010.1694">Hasegawa et al 2010</a>]. The clinical presentation varies depending on the age of onset. The cardinal features in children are ataxia, intellectual disability, behavioral changes, myoclonus, and epilepsy; cardinal features in adults are ataxia, choreoathetosis, and dementia [<a class="bk_pop" href="#drpla.REF.tsuji.2012.587">Tsuji 2012</a>].</p><p>Studies have shown that ataxia and cognitive impairment are cardinal features irrespective of the age of onset [<a class="bk_pop" href="#drpla.REF.ikeuchi.1995b.769">Ikeuchi et al 1995b</a>].</p><p>Individuals with onset before age 20 years usually have a progressive myoclonus epilepsy (PME) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> characterized by myoclonus, seizures, ataxia, and progressive intellectual deterioration [<a class="bk_pop" href="#drpla.REF.naito.1982.798">Naito &#x00026; Oyanagi 1982</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995b.769">Ikeuchi et al 1995b</a>, <a class="bk_pop" href="#drpla.REF.tsuji.2012.587">Tsuji 2012</a>]. Various forms of generalized seizures (including tonic, atonic, clonic, or tonic-clonic seizures) are also observed [<a class="bk_pop" href="#drpla.REF.tsuji.2012.587">Tsuji 2012</a>].</p><p>Seizures are less frequent in individuals with onset between ages 20 and 40 years. Seizures are rare in individuals with onset after age 40 years and a CAG repeat size lower than 65 [<a class="bk_pop" href="#drpla.REF.hasegawa.2010.1694">Hasegawa et al 2010</a>, <a class="bk_pop" href="#drpla.REF.tsuji.2012.587">Tsuji 2012</a>].</p><p>Individuals with onset of DRPLA after age 20 years tend to develop cerebellar ataxia, choreoathetosis, dementia, and psychiatric disturbances (non-PME <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>). In some individuals, involuntary movements and dementia mask the presence of ataxia. Psychosis may sometimes be a presenting feature [<a class="bk_pop" href="#drpla.REF.adachi.2001.258">Adachi et al 2001</a>].</p><p>Cervical dystonia was the presenting feature in one family [<a class="bk_pop" href="#drpla.REF.hatano.2003.287">Hatano et al 2003</a>].</p><p><b>Neuroimaging.</b> Atrophic changes in the cerebellum and brain stem, in particular the pontine tegmentum, are the typical MRI findings of DRPLA. Quantitative analyses revealed that both the age at MRI and the size of the expanded CAG repeat correlate with the atrophic changes.</p><p>Diffuse high-intensity areas deep in the white matter are often observed on T<sub>2</sub>-weighted MRI in individuals with adult-onset DRPLA of long duration [<a class="bk_pop" href="#drpla.REF.koide.1997.1605">Koide et al 1997</a>].</p><p>Using <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography (18F-FDG-PET), bistriatal glucose hypometabolism was reported in two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with preadolescent-onset disease; this was not present in individuals with later-onset disease [<a class="bk_pop" href="#drpla.REF.sone.2016.121">Sone et al 2016</a>].</p><p><b>Neuropathology.</b> The major neuropathologic changes are relatively simple and consist of combined degeneration of the dentatorubral and pallidoluysian systems. Cerebral white matter damage, including diffuse myelin pallor, axonal preservation, and reactive astrogliosis with only mild atherosclerotic changes, has been described at autopsy [<a class="bk_pop" href="#drpla.REF.mu_oz.2004.946">Mu&#x000f1;oz et al 2004</a>]. Histologically, as in other polyglutamine diseases, neurons show intranuclear inclusions [<a class="bk_pop" href="#drpla.REF.mori.2012a.134">Mori et al 2012a</a>, <a class="bk_pop" href="#drpla.REF.mori.2012b.747">Mori et al 2012b</a>].</p><p>See <a href="#drpla.Molecular_Pathogenesis">Molecular Pathogenesis</a> for further information on the pathogenesis of DRPLA.</p></div><div id="drpla.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b>Heterozygotes.</b> In general, an inverse correlation exists between the age at onset and the size of the expanded <i>ATN1</i> CAG repeat [<a class="bk_pop" href="#drpla.REF.koide.1994.9">Koide et al 1994</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995b.769">Ikeuchi et al 1995b</a>] (see <a class="figpopup" href="/books/NBK1491/table/drpla.T.correlation_between_age_at_onset/?report=objectonly" target="object" rid-figpopup="figdrplaTcorrelationbetweenageatonset" rid-ob="figobdrplaTcorrelationbetweenageatonset">Table 2</a>).</p><p>Note: <i>ATN1</i> CAG repeat ranges overlap and the distinctions are not clearly defined.</p><div id="drpla.T.correlation_between_age_at_onset" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Correlation between Age at Onset and Size of <i>ATN1</i> Repeat</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1491/table/drpla.T.correlation_between_age_at_onset/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__drpla.T.correlation_between_age_at_onset_lrgtbl__"><table><thead><tr><th id="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_1" style="text-align:left;vertical-align:middle;">Age at Onset</th><th id="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>ATN1</i> CAG Repeat Size</th></tr><tr><th headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2" id="hd_h_drpla.T.correlation_between_age_at_onset_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Range</th><th headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2" id="hd_h_drpla.T.correlation_between_age_at_onset_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Median</th></tr></thead><tbody><tr><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;21 years</td><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2 hd_h_drpla.T.correlation_between_age_at_onset_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">63-79</td><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2 hd_h_drpla.T.correlation_between_age_at_onset_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">68</td></tr><tr><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21-40 years</td><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2 hd_h_drpla.T.correlation_between_age_at_onset_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">61-69</td><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2 hd_h_drpla.T.correlation_between_age_at_onset_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">64</td></tr><tr><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;40 years</td><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2 hd_h_drpla.T.correlation_between_age_at_onset_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">48-67</td><td headers="hd_h_drpla.T.correlation_between_age_at_onset_1_1_1_2 hd_h_drpla.T.correlation_between_age_at_onset_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">63</td></tr></tbody></table></div></div><p>Because onset before age 20 years is associated with the progressive myoclonus epilepsy (PME) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and an older age of onset with the non-PME phenotype, the clinical presentation is strongly correlated with the size of expanded CAG repeats. The frequency of signs and symptoms in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with fewer than 65 CAG repeats and those with 65 or more CAG repeats are summarized in <a class="bk_pop" href="#drpla.REF.hasegawa.2010.1694">Hasegawa et al [2010]</a>.</p><p>Severe infantile onset with an <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> with an extreme <i>ATN1</i> CAG expansion of 90-93 CAG repeats [<a class="figpopup" href="/books/NBK1491/table/drpla.T.selected_atn1_variants/?report=objectonly" target="object" rid-figpopup="figdrplaTselectedatn1variants" rid-ob="figobdrplaTselectedatn1variants">c.1462CAG(90-93)</a>] has been reported [<a class="bk_pop" href="#drpla.REF.shimojo.2001.277">Shimojo et al 2001</a>].</p><p><b>Homozygotes.</b> A single individual who had relatively small <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> expanded <i>ATN1</i> CAG repeat alleles is reported to have had symptom onset at 14 years, indicating a possible dosage effect [<a class="bk_pop" href="#drpla.REF.sato.1995.1934">Sato et al 1995</a>].</p></div><div id="drpla.Penetrance"><h3>Penetrance</h3><p>Expanded alleles are fully penetrant except for one individual with a mildly expanded number of CAG repeats (51 repeats) who was asmptomatic at age 81 years [<a class="bk_pop" href="#drpla.REF.hattori.1999.287">Hattori et al 1999</a>].</p></div><div id="drpla.Anticipation"><h3>Anticipation</h3><p>The marked expansion of the CAG repeat during transmission of pathogenic <i>ATN1</i> alleles from parent to child results in prominent <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a>. Affected offspring typically have symptoms 26 to 29 years earlier than <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fathers and 14 to 15 years earlier than affected mothers [<a class="bk_pop" href="#drpla.REF.koide.1994.9">Koide et al 1994</a>, <a class="bk_pop" href="#drpla.REF.nagafuchi.1994.14">Nagafuchi et al 1994</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995a.23">Ikeuchi et al 1995a</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995b.769">Ikeuchi et al 1995b</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995c.37">Ikeuchi et al 1995c</a>, <a class="bk_pop" href="#drpla.REF.hattori.1999.287">Hattori et al 1999</a>, <a class="bk_pop" href="#drpla.REF.vinton.2005.201">Vinton et al 2005</a>].</p></div><div id="drpla.Nomenclature"><h3>Nomenclature</h3><p>DRPLA may also be referred to as Naito-Oyanagi disease, after the individuals who first observed the age-dependent onset of symptoms and the robust heritability of the condition [<a class="bk_pop" href="#drpla.REF.kanazawa.1998.1">Kanazawa 1998</a>]. DRPLA in a large African American family in North Carolina was referred to as Haw River syndrome [<a class="bk_pop" href="#drpla.REF.burke.1994a.1711">Burke et al 1994a</a>, <a class="bk_pop" href="#drpla.REF.burke.1994b.521">Burke et al 1994b</a>].</p></div><div id="drpla.Prevalence"><h3>Prevalence</h3><p>The prevalence of DRPLA in the Japanese population is estimated at 0.48:100,000 based on the nationwide study [<a class="bk_pop" href="#drpla.REF.tsuji.2008.189">Tsuji et al 2008</a>]. Analysis of the distribution of normal <i>ATN1</i> alleles by size has demonstrated that CAG repeats larger than 17 repeats are significantly more frequent in the Japanese population than in populations of European origin, which is in accordance with the observation that DRPLA is relatively more common among the Japanese than other ethnic populations [<a class="bk_pop" href="#drpla.REF.takano.1998.1060">Takano et al 1998</a>].</p><p>Although DRPLA has been reported to occur predominantly in the Japanese, individuals with molecularly confirmed DRPLA have been identified in other populations including European and North and South American [<a class="bk_pop" href="#drpla.REF.burke.1994b.521">Burke et al 1994b</a>, <a class="bk_pop" href="#drpla.REF.le_ber.2003.1097">Le Ber et al 2003</a>, <a class="bk_pop" href="#drpla.REF.martins.2003.808">Martins et al 2003</a>, <a class="bk_pop" href="#drpla.REF.wardle.2009.1636">Wardle et al 2009</a>, <a class="bk_pop" href="#drpla.REF.paradisi.2016.215">Paradisi et al 2016</a>]. Analyses of some Italian families with DRPLA show that the haplotype associated with DRPLA is very similar to the Japanese and Portuguese haplotype, suggesting a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> [<a class="bk_pop" href="#drpla.REF.veneziano.2014.153">Veneziano et al 2014</a>].</p><p>Although rare in the US, DRPLA has been identified in a large African American family in North Carolina [<a class="bk_pop" href="#drpla.REF.burke.1994a.1711">Burke et al 1994a</a>, <a class="bk_pop" href="#drpla.REF.burke.1994b.521">Burke et al 1994b</a>] and in a second African American family [<a class="bk_pop" href="#drpla.REF.licht.2002.51">Licht &#x00026; Lynch 2002</a>].</p></div></div><div id="drpla.Genetically_Related_Allelic_Disord"><h2 id="_drpla_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ATN1</i>.</p></div><div id="drpla.Differential_Diagnosis"><h2 id="_drpla_Differential_Diagnosis_">Differential Diagnosis</h2><p>For individuals with adult-onset dentatorubral-pallidoluysian atrophy (DRPLA) who exhibit ataxia, dementia, or choreoathetosis (the non-PME <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>), the differential diagnosis includes the following.</p><p><a href="/books/n/gene/huntington/"><b>Huntington disease</b></a> and Huntington disease-like phenotypes including Huntington disease-like 1 (see <a href="/books/n/gene/prion/">Genetic Prion Diseases</a>) and <a href="/books/n/gene/hd-l2/">Huntington disease-like 2</a>. The presence of ataxia is important for differentiating DRPLA from Huntington disease. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with the non-PME <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of DRPLA may initially be diagnosed as having Huntington disease, as the main clinical features in these individuals are involuntary movements and dementia, symptoms that often mask the presence of ataxia. The history of ataxia as an early symptom as well as atrophy of the cerebellum and brain stem (particularly pontine tegmentum) on imaging study is important in the differential diagnosis. Atrophy of the caudate nucleus favors the diagnosis of Huntington disease. It is frequently necessary to do <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for Huntington disease, Huntington disease-like phenotypes, and DRPLA in individuals with unexplained progressive dementia and involuntary movements.</p><p><b>Ataxia.</b> Individuals with DRPLA who have mildly expanded CAG repeats [<a class="figpopup" href="/books/NBK1491/table/drpla.T.selected_atn1_variants/?report=objectonly" target="object" rid-figpopup="figdrplaTselectedatn1variants" rid-ob="figobdrplaTselectedatn1variants">c.1462CAG(49-55)</a>] tend to exhibit, particularly in early stages, pure cerebellar symptoms such as ataxia without dementia, choreoathetosis, or character changes, making the clinical diagnosis of DRPLA difficult. Such individuals need to be distinguished from those with ataxia of other etiologies including the dominantly inherited ataxias for which the involved genes are known (e.g., <a href="/books/n/gene/sca1/">SCA1</a>, <a href="/books/n/gene/sca2/">SCA2</a>, <a href="/books/n/gene/sca3/">Machado-Joseph disease</a> [SCA3], <a href="/books/n/gene/sca6/">SCA6</a>, <a href="/books/n/gene/sca7/">SCA7</a>, <a href="/books/n/gene/sca17/">SCA17</a>) and other dominant SCAs (see <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>).</p><p><b>Progressive intellectual deterioration, myoclonus, and epilepsy.</b> For those with early-onset DRPLA (age &#x0003c;20 years), the differential diagnosis includes the following (see also <a class="bk_pop" href="#drpla.REF.malek.2015.164">Malek et al [2015]</a>):</p><ul><li class="half_rhythm"><div>Benign adult <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> myoclonus epilepsy (also called familial essential myoclonus and epilepsy). See <a href="http://omim.org/phenotypicSeries/PS601068" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Familial adult myoclonic epilepsy: OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/gaucher/">Gaucher disease</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/tay-sachs/">Hexosaminidase A deficiency</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/inad/">Infantile neuroaxonal dystrophy</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/merrf/">MERRF</a> (myoclonus epilepsy associated with ragged-red fibers)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/neuroferritin/">Neuroferritinopathy</a></div></li><li class="half_rhythm"><div>Neuronal ceroid-lipofuscinosis</div></li><li class="half_rhythm"><div><a href="/books/n/gene/pkan/">Pantothenate kinase associated neurodegeneration</a></div></li><li class="half_rhythm"><div>Progressive myoclonic epilepsy type 4, 5, 6</div></li><li class="half_rhythm"><div><a href="/books/n/gene/lafora/">Progressive myoclonus epilepsy, Lafora type</a></div></li><li class="half_rhythm"><div>Sialidosis (OMIM <a href="http://omim.org/entry/256550" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">256550</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/epm1/">Unverricht-Lundborg disease</a></div></li></ul></div><div id="drpla.Management"><h2 id="_drpla_Management_">Management</h2><div id="drpla.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with dentatorubral-pallidoluysian atrophy (DRPLA), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>EEG in the presence of seizures</div></li><li class="half_rhythm"><div>Head MRI to monitor progression of the disease</div></li><li class="half_rhythm"><div>Neuropsychological testing for evidence of dementia and psychiatric disturbance</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li><li class="half_rhythm"><div>Consultation with a rehabilitation therapist</div></li></ul></div><div id="drpla.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Treatment of seizures with antiepileptic drugs (AEDs) in a standard manner</div></li><li class="half_rhythm"><div>Treatment of psychiatric problems with appropriate psychotropic medications</div></li><li class="half_rhythm"><div>Symptomatic treatment of ataxia using riluzole and rehabilitation therapy [<a class="bk_pop" href="#drpla.REF.van_de_warrenburg.2014.552">van de Warrenburg et al 2014</a>, <a class="bk_pop" href="#drpla.REF.romano.2015.985">Romano et al 2015</a>]</div></li><li class="half_rhythm"><div>Adaptation of environment and care to the level of dementia</div></li><li class="half_rhythm"><div>For <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children, adaptation of educational programming to abilities</div></li></ul></div><div id="drpla.Surveillance"><h3>Surveillance</h3><p>Surveillance is individualized based on disease progression.</p></div><div id="drpla.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>General anesthesia can increase the risk of intra- and postoperative seizures [<a class="bk_pop" href="#drpla.REF.takayama.2002.902">Takayama et al 2002</a>].</p></div><div id="drpla.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#drpla.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="drpla.Pregnancy_Management"><h3>Pregnancy Management</h3><p>In general, women with epilepsy or a seizure disorder from any cause are at greater risk for mortality during pregnancy than pregnant women without a seizure disorder; use of antiepileptic medication during pregnancy reduces this risk. However, exposure to antiepileptic medication may increase the risk for adverse fetal outcome (depending on the drug used, the dose, and the stage of pregnancy at which the medication is taken). Nevertheless, the risk of an adverse outcome to the fetus from medication exposure is often less than that associated with exposure to an untreated maternal seizure disorder. Therefore, use of antiepileptic medication during pregnancy is typically recommended. Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception. Transitioning to a lower-risk medication prior to pregnancy may be possible [<a class="bk_pop" href="#drpla.REF.sarma.2016.467">Sarma et al 2016</a>].</p><p>The use of riluzole during pregnancy has not been well studied in humans. One woman took riluzole throughout her pregnancy and delivered a healthy term infant whereas another woman delivered an infant with growth restriction [<a class="bk_pop" href="#drpla.REF.kawamichi.2010.720">Kawamichi et al 2010</a>, <a class="bk_pop" href="#drpla.REF.scalco.2012.471">Scalco et al 2012</a>].</p><p>See <a href="http://mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby.org</a> for further information on medication use during pregnancy.</p></div><div id="drpla.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="drpla.Genetic_Counseling"><h2 id="_drpla_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="drpla.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>DRPLA is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="drpla.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with DRPLA have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>It is appropriate to evaluate both parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> even if they are asymptomatic.</div></li><li class="half_rhythm"><div>In some cases, an asymptomatic father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a mildly expanded CAG repeat and paternal transmission results in intergenerational increase in the size of the expanded CAG repeats. Examples include:</div><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with no family history of DRPLA whose father had 59 CAG repeats and was asymptomatic at age 65 years [<a class="bk_pop" href="#drpla.REF.ikeuchi.1995b.769">Ikeuchi et al 1995b</a>];</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with no family history of DRPLA whose father had 51 CAG repeats and was asymptomatic at 81 years [<a class="bk_pop" href="#drpla.REF.hattori.1999.287">Hattori et al 1999</a>].</div></li></ul></li><li class="half_rhythm"><div>The family history of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may also appear to be negative because of failure to recognize the disorder in family members [<a class="bk_pop" href="#drpla.REF.ikeuchi.1995b.769">Ikeuchi et al 1995b</a>] or early death of the parent before the onset of symptoms.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/full-penetrance-allele/">full-penetrance allele</a>, the risk to the sibs is 50%. The clinical features expected in the sib depend on the size of the repeat transmitted to the sib, which in turn depends on the size of the parent's repeat and the gender of the transmitting parent.</div></li><li class="half_rhythm"><div>If a parent has a mutable normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, the risk of a full <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> allele in a sib is presumably lower than 50%. However, because the finding of a mutable normal allele in a parent of an individual with DRPLA has not been reported to date, no precise estimate can be calculated.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the children of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual of inheriting an expanded CAG repeat is 50%. The size of the repeat transmitted to the offspring depends on the size of the parent's repeat and the gender of the transmitting parent.</div></li><li class="half_rhythm"><div>DRPLA exhibits significant <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a>. See <a href="#drpla.Anticipation">Anticipation</a>.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a mutable normal or <a class="def" href="/books/n/gene/glossary/def-item/full-penetrance-allele/">full-penetrance allele</a>, his or her family members are at risk.</p></div><div id="drpla.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>Testing of at-risk adult relatives</b></p><ul><li class="half_rhythm"><div>Testing of at-risk adults for DRPLA in the presence of nonspecific or equivocal symptoms is predictive testing, not diagnostic testing. When testing at-risk individuals for DRPLA, it is helpful to first test for the <i>ATN1</i> (<i>DRPLA</i>) CAG expansion in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member to confirm the molecular diagnosis in the family.</div></li><li class="half_rhythm"><div>Testing of asymptomatic, healthy at-risk adults for DRPLA can be performed, taking into consideration their autonomy of choice and right to privacy.</div></li></ul><p><b>Predictive testing (i.e., testing of asymptomatic at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for at-risk relatives is possible once the <i>ATN1</i> (<i>DRPLA</i>) CAG expansion has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div></li><li class="half_rhythm"><div>Potential consequences of such testing (including but not limited to socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li></ul><p><b>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals younger than age 18 years)</b></p><ul><li class="half_rhythm"><div>Predictive testing of minors for adult-onset disorders for which no treatment exists is not considered appropriate. Such testing negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</div></li><li class="half_rhythm"><div>See also the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</div></li></ul><p>It is appropriate to consider testing symptomatic individuals regardless of age in a family with an established diagnosis of DRPLA.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="drpla.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ATN1</i> (<i>DRPLA</i>) CAG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansion has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for DRPLA are possible.</p></div></div><div id="drpla.Resources"><h2 id="_drpla_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>Spanish Ataxia Federation (FEDAES)</b></div><div>Spain</div><div><b>Phone:</b> 34 983 278 029; 34 985 097 152; 34 634 597 503</div><div><b>Email:</b> sede.valladolid@fedaes.org; sede.gijon@fedaes.org; sede.bilbao@fedaes.org</div><div><a href="http://www.fedaes.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fedaes.org</a></div></li><li class="half_rhythm"><div><b>CoRDS Registry</b></div><div>Sanford Research</div><div>2301 East 60th Street North</div><div>Sioux Falls SD 57104</div><div><b>Phone:</b> 605-312-6423</div><div><b>Email:</b> sanfordresearch@sanfordhealth.org</div><div><a href="http://www.sanfordresearch.org/SpecialPrograms/cords/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CoRDS Registry</a></div></li></ul></div><div id="drpla.Molecular_Genetics"><h2 id="_drpla_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="drpla.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>DRPLA: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1491/table/drpla.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__drpla.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_drpla.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_drpla.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_drpla.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_drpla.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_drpla.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_drpla.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_drpla.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1822" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ATN1</i></a></td><td headers="hd_b_drpla.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1822" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12p13<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_drpla.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P54259" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Atrophin-1</a></td><td headers="hd_b_drpla.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ATN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATN1 database</a></td><td headers="hd_b_drpla.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ATN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATN1</a></td><td headers="hd_b_drpla.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ATN1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATN1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="drpla.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="drpla.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for DRPLA (<a href="/omim/125370,607462" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1491/table/drpla.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__drpla.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/125370" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">125370</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607462" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607462</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATROPHIN 1; ATN1</td></tr></tbody></table></div></div><div id="drpla.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>As in other polyglutamine disorders, the disease-causing CAG expansion in <i>DRPLA</i> (<i>ATN1</i>) led to the identification of neuronal intranuclear protein aggregates, or intranuclear inclusions (NIIs) in the brains of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#drpla.REF.hayashi.1998.479">Hayashi et al 1998</a>, <a class="bk_pop" href="#drpla.REF.igarashi.1998.111">Igarashi et al 1998</a>, <a class="bk_pop" href="#drpla.REF.mori.2012a.134">Mori et al 2012a</a>, <a class="bk_pop" href="#drpla.REF.mori.2012b.747">Mori et al 2012b</a>]. Accumulation of abnormal DRPLA protein (atrophin-1) in the neuronal nuclei is the predominant neuropathologic finding. Of note, NIIs are observed in central nervous system regions far beyond the systems previously reported to be affected on conventional neuropathologic findings. It has been suggested that NIIs are responsible for clinical features such as dementia and epilepsy [<a class="bk_pop" href="#drpla.REF.yamada.2000.615">Yamada et al 2000</a>, <a class="bk_pop" href="#drpla.REF.yamada.2001.14">Yamada et al 2001</a>, <a class="bk_pop" href="#drpla.REF.yamada.2002.317">Yamada et al 2002</a>].</p><p><b>Animal models.</b> Studies of mouse models suggest that neuronal dysfunction without neuronal death is the essential pathophysiologic process and that age-dependent neuronal intranuclear accumulation (NIA) underlies the neuronal dysfunction in DRPLA.</p><p>Mouse models for DRPLA expressing full-length human <i>ATN1</i> with CAG expansion have been created [<a class="bk_pop" href="#drpla.REF.sato.1999b.99">Sato et al 1999b</a>, <a class="bk_pop" href="#drpla.REF.sato.2009.723">Sato et al 2009</a>].</p><p>Mice expressing 76 CAG repeats exhibited intergenerational instability of CAG repeats (as similarly observed in families with DRPLA), but no obvious neurologic phenotypes. Mice with 129 CAG repeats exhibited devastating progressive neurologic phenotypes similar to individuals with juvenile-onset DRPLA. Neurologic dysfunction of the globus pallidus (GP) and cerebellum was observed, as well as progressive shrinkage of distal dendrites of Purkinje cells (PCs) and progressive brain atrophy, but no obvious neuronal loss. Neuronal abnormalities are associated with massive NIIs. Abnormalities in individual neurons including reductions in the number and size of spines as well as in the area of perikarya and diameter of dendrites were also observed. These abnormalities probably explain the brain atrophy and neuronal dysfunction in this disease [<a class="bk_pop" href="#drpla.REF.sakai.2006.2353">Sakai et al 2006</a>, <a class="bk_pop" href="#drpla.REF.sato.2009.723">Sato et al 2009</a>, <a class="bk_pop" href="#drpla.REF.suzuki.2012.336">Suzuki et al 2012</a>, <a class="bk_pop" href="#drpla.REF.suzuki.2013.277">Suzuki et al 2013</a>].</p><p>Recently lysine-specific demethylase 1 (LSD1) and its target ATN1 were shown to be responsible for neuronal progenitor cell maintenance during cortical development in vivo [<a class="bk_pop" href="#drpla.REF.zhang.2014">Zhang et al 2014</a>].</p><p><b>Gene structure.</b>
<i>ATN1</i> comprises ten exons spanning 20 kb; it is alternatively spliced resulting in two transcript variants (<a href="/nuccore/55750052" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001007026.1</a> and <a href="/nuccore/NM_001940.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001940.3</a>) that encode the same protein with differences only in their untranslated exons (<a href="/protein/55750053" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001007027.1</a> and <a href="/protein/NP_001931.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001931.2</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1491/#drpla.molgen.TA">Table A</a>, <b>Gene.</b></p><p><b>Benign variants.</b> The CAG repeat in <i>ATN1</i> is located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5, 1,462 bp downstream from the putative methionine initiation codon, and is predicted to code for a polyglutamine stretch. The CAG repeats in normal individuals range from six to 35 repeat units [<a class="bk_pop" href="#drpla.REF.koide.1994.9">Koide et al 1994</a>, <a class="bk_pop" href="#drpla.REF.nagafuchi.1994.14">Nagafuchi et al 1994</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995a.23">Ikeuchi et al 1995a</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995c.37">Ikeuchi et al 1995c</a>].</p><p><b>Mutable normal alleles.</b> Mutable normal alleles may exist; <a class="bk_pop" href="#drpla.REF.takano.1998.1060">Takano et al [1998]</a> have shown that the normal Japanese population has a greater number of individuals with 20-35 CAG repeats than are found in populations of European origin. Mutable normal alleles are not associated with symptoms but are hypothetically unstable and could expand on transmission resulting in occurrence of symptoms in the next generation. However, no case of a mutable <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> expanding or contracting in the subsequent generation has been reported.</p><p><b>Pathogenic variants.</b> The CAG repeats in individuals with DRPLA range from 48 to 93 repeat units [<a class="bk_pop" href="#drpla.REF.koide.1994.9">Koide et al 1994</a>, <a class="bk_pop" href="#drpla.REF.nagafuchi.1994.14">Nagafuchi et al 1994</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995a.23">Ikeuchi et al 1995a</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995b.769">Ikeuchi et al 1995b</a>, <a class="bk_pop" href="#drpla.REF.ikeuchi.1995c.37">Ikeuchi et al 1995c</a>, <a class="bk_pop" href="#drpla.REF.alford.1997.354">Alford et al 1997</a>, <a class="bk_pop" href="#drpla.REF.shimojo.2001.277">Shimojo et al 2001</a>] (for more information, see <a href="/books/NBK1491/#drpla.molgen.TA">Table A</a>).</p><div id="drpla.T.selected_atn1_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>ATN1</i> Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1491/table/drpla.T.selected_atn1_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__drpla.T.selected_atn1_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_drpla.T.selected_atn1_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_drpla.T.selected_atn1_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_drpla.T.selected_atn1_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_drpla.T.selected_atn1_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Benign</b></td><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1462CAG(6_35)<br />(CAG 6-35 repeats)</td><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote&#x000a0;1</td><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_4" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/55750052" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001007026<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/55750053" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001007027<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1462CAG(49_55)&#x000a0;<sup>2</sup></td><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote&#x000a0;2</td></tr><tr><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1462CAG(48_93)<br />(CAG 48-93 repeats)</td><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote&#x000a0;1</td></tr><tr><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1462CAG(90_93)&#x000a0;<sup>3</sup><br />(CAG 90-93 repeats)</td><td headers="hd_h_drpla.T.selected_atn1_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote&#x000a0;1</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="drpla.TF.3.1"><p class="no_margin">Each CAG repeat results in the addition of a glutamine residue to the polymorphic polyglutamine repeat.</p></div></dd><dt>2. </dt><dd><div id="drpla.TF.3.2"><p class="no_margin">See <a href="#drpla.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd><dt>3. </dt><dd><div id="drpla.TF.3.3"><p class="no_margin">See <a href="#drpla.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>ATN1</i> <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> is predicted to code for 1,190 amino acids. Atrophin-1 is a nuclear protein with putative nuclear localizing signals [<a class="bk_pop" href="#drpla.REF.sato.1999a.997">Sato et al 1999a</a>, <a class="bk_pop" href="#drpla.REF.nucifora.2003.13047">Nucifora et al 2003</a>]. Several studies have suggested that the <i>Drosophila</i> ortholog of atrophin-1 (DRPLA protein) functions as a transcriptional co-regulator in diverse developmental processes [<a class="bk_pop" href="#drpla.REF.wood.2000.939">Wood et al 2000</a>, <a class="bk_pop" href="#drpla.REF.zhang.2002.45">Zhang et al 2002</a>, <a class="bk_pop" href="#drpla.REF.charroux.2006.278">Charroux et al 2006</a>, <a class="bk_pop" href="#drpla.REF.shen.2007.5037">Shen et al 2007</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Expression of truncated proteins encoded by <i>ATN1</i> with expanded polyglutamine stretches result in frequent formation of peri- and intranuclear aggregates and apoptotic cell death, suggesting that processed expanded proteins are more toxic to cells than full-length proteins [<a class="bk_pop" href="#drpla.REF.igarashi.1998.111">Igarashi et al 1998</a>, <a class="bk_pop" href="#drpla.REF.shimohata.2002.215">Shimohata et al 2002</a>]. Expanded polyglutamine stretches have been shown to interact with TATA-binding protein (TBP)-associated factors (TAFII130) or cAMP response element-binding protein (CREB)-binding protein (CBP), resulting in the suppression of CREB-dependent transcriptional activation that is vital for neuronal survival and plasticity [<a class="bk_pop" href="#drpla.REF.shimohata.2000.29">Shimohata et al 2000</a>, <a class="bk_pop" href="#drpla.REF.nucifora.2001.2423">Nucifora et al 2001</a>, <a class="bk_pop" href="#drpla.REF.shimohata.2005.654">Shimohata et al 2005</a>].</p></div></div><div id="drpla.References"><h2 id="_drpla_References_">References</h2><div id="drpla.Published_Guidelines__Consensus_St"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="drpla.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 3-29-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset conditions. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 3-29-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF3">EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. <span><span class="ref-journal">Eur J Neurol. </span>2014 Apr;<span class="ref-vol">21</span>(4):552–62.</span> [<a href="/pubmed/24418350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24418350</span></a>]</div></li></ul></div><div id="drpla.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.adachi.2001.258">Adachi N, Arima K, Asada T, Kato M, Minami N. Goto Yi, Onuma T, Ikeuchi T, Tsuji S, Hayashi M, Fukutani Y. Dentatorubral-pallidoluysian atrophy (DRPLA) presenting with psychosis. <span><span class="ref-journal">J Neuropsychiatry Clin Neurosci. </span>2001;<span class="ref-vol">13</span>:258–60.</span> [<a href="/pubmed/11449034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11449034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.alford.1997.354">Alford RL, Margolis RL, Ross CA, Richards CS. Southern analysis for detection of CAG repeat expansions associated with dentatorubral pallidoluysian atrophy. <span><span class="ref-journal">Hum Genet. </span>1997;<span class="ref-vol">99</span>:354–6.</span> [<a href="/pubmed/9050922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9050922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.burke.1994a.1711">Burke JR, Ikeuchi T, Koide R, Tsuji S, Yamada M, Pericak-Vance MA, Vance JM. Dentatorubral-pallidoluysian atrophy and Haw River syndrome. <span><span class="ref-journal">Lancet. </span>1994a;<span class="ref-vol">344</span>:1711–2.</span> [letter] [<a href="/pubmed/7996992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7996992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.burke.1994b.521">Burke JR, Wingfield MS, Lewis KE, Roses AD, Lee JE, Hulette C, Pericak-Vance MA, Vance JM. The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family. <span><span class="ref-journal">Nat Genet. </span>1994b;<span class="ref-vol">7</span>:521–4.</span> [<a href="/pubmed/7951323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7951323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.charroux.2006.278">Charroux B, Freeman M, Kerridge S, Baonza A. Atrophin contributes to the negative regulation of epidermal growth factor receptor signaling in Drosophila. <span><span class="ref-journal">Dev Biol. </span>2006;<span class="ref-vol">291</span>:278–90.</span> [<a href="/pubmed/16445904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16445904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.hasegawa.2010.1694">Hasegawa A, Ikeuchi T, Koike R, Matsubara N, Tsuchiya M, Nozaki H, Homma A, Idezuka J, Nishizawa M, Onodera O. Long-term disability and prognosis in dentatorubral-pallidoluysian atrophy: a correlation with CAG repeat length. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:1694–700.</span> [<a href="/pubmed/20589872" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20589872</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.hatano.2003.287">Hatano T, Okuma Y, Iijima M, Fujishima K, Goto K, Mizuno Y. Cervical dystonia in dentatorubral-pallidoluysian atrophy. <span><span class="ref-journal">Acta Neurol Scand. </span>2003;<span class="ref-vol">108</span>:287–9.</span> [<a href="/pubmed/12956864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12956864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.hattori.1999.287">Hattori M, Yuasa H, Takada K, Yamada T, Yamada K, Kamimoto K, Uchida M. Genetic analysis of a dentatorubral-pallidoluysian atrophy family: relevance to apparent sporadic cases. <span><span class="ref-journal">Intern Med. </span>1999;<span class="ref-vol">38</span>:287–9.</span> [<a href="/pubmed/10337944" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10337944</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.hayashi.1998.479">Hayashi Y, Kakita A, Yamada M, Egawa S, Oyanagi S, Naito H, Tsuji S, Takahashi H. Hereditary dentatorubral-pallidoluysian atrophy: ubiquitinated filamentous inclusions in the cerebellar dentate nucleus neurons. <span><span class="ref-journal">Acta Neuropathol (Berl). </span>1998;<span class="ref-vol">95</span>:479–82.</span> [<a href="/pubmed/9600594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9600594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.igarashi.1998.111">Igarashi S, Koide R, Shimohata T, Yamada M, Hayashi Y, Takano H, Date H, Oyake M, Sato T, Sato A, Egawa S, Ikeuchi T, Tanaka H, Nakano R, Tanaka K, Hozumi I, Inuzuka T, Takahashi H, Tsuji S. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">18</span>:111–7.</span> [<a href="/pubmed/9462738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9462738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.ikeuchi.1995a.23">Ikeuchi T, Koide R, Onodera O, Tanaka H, Oyake M, Takano H, Tsuji S. Dentatorubral-pallidoluysian atrophy (DRPLA). Molecular basis for wide clinical features of DRPLA. <span><span class="ref-journal">Clin Neurosci. </span>1995a;<span class="ref-vol">3</span>:23–7.</span> [<a href="/pubmed/7614090" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7614090</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.ikeuchi.1995b.769">Ikeuchi T, Koide R, Tanaka H, Onodera O, Igarashi S, Takahashi H, Kondo R, Ishikawa A, Tomoda A, Miike T, Sata K, Ihara Y, Hayabara T, Isa F, Tanabe H, Tokiguchi S, Yayashi M, Shimizu N, Ikuta F, Naito H, Tsuji S. Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat. <span><span class="ref-journal">Ann Neurol. </span>1995b;<span class="ref-vol">37</span>:769–75.</span> [<a href="/pubmed/7778850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7778850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.ikeuchi.1995c.37">Ikeuchi T, Onodera O, Oyake M, Koide R, Tanaka H, Tsuji S. Dentatorubral-pallidoluysian atrophy (DRPLA): close correlation of CAG repeat expansions with the wide spectrum of clinical presentations and prominent anticipation. <span><span class="ref-journal">Semin Cell Biol. </span>1995c;<span class="ref-vol">6</span>:37–44.</span> [<a href="/pubmed/7620120" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7620120</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.kanazawa.1998.1">Kanazawa I. Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease. <span><span class="ref-journal">Neurogenetics. </span>1998;<span class="ref-vol">2</span>:1–17.</span> [<a href="/pubmed/9933295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9933295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.kawamichi.2010.720">Kawamichi Y, Makino Y, Matsuda Y, Miyazaki K, Uchiyama S, Ohta H. Riluzole use during pregnancy in a patient with amyotrophic lateral sclerosis: a case report. <span><span class="ref-journal">J Int Med Res. </span>2010;<span class="ref-vol">38</span>:720–6.</span> [<a href="/pubmed/20515588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20515588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.koide.1994.9">Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Saito M, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). <span><span class="ref-journal">Nat Genet. </span>1994;<span class="ref-vol">6</span>:9–13.</span> [<a href="/pubmed/8136840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8136840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.koide.1997.1605">Koide R, Onodera O, Ikeuchi T, Kondo R, Tanaka H, Tokiguchi S, Tomoda A, Miike T, Isa F, Beppu H, Shimizu N, Watanabe Y, Horikawa Y, Shimohata T, Hirota K, Ishikawa A, Tsuji S. Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy. Influence of CAG repeat size on MRI findings. <span><span class="ref-journal">Neurology. </span>1997;<span class="ref-vol">49</span>:1605–12.</span> [<a href="/pubmed/9409354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9409354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.le_ber.2003.1097">Le Ber I, Camuzat A, Castelnovo G, Azulay JP, Genton P, Gastaut JL, Broglin D, Labauge P, Brice A, Durr A. Prevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:1097–9.</span> [<a href="/pubmed/12925365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12925365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.licht.2002.51">Licht DJ, Lynch DR. Juvenile dentatorubral-pallidoluysian atrophy: new clinical features. <span><span class="ref-journal">Pediatr Neurol. </span>2002;<span class="ref-vol">26</span>:51–4.</span> [<a href="/pubmed/11814736" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11814736</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.malek.2015.164">Malek N, Stewart W, Greene J. The progressive myoclonic epilepsies. <span><span class="ref-journal">Pract Neurol. </span>2015;<span class="ref-vol">15</span>:164–71.</span> [<a href="/pubmed/25720773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25720773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.martins.2003.808">Martins S, Matama T, Guimaraes L, Vale J, Guimaraes J, Ramos L, Coutinho P, Sequeiros J, Silveira I. Portuguese families with dentatorubropallidoluysian atrophy (DRPLA) share a common haplotype of Asian origin. <span><span class="ref-journal">Eur J Hum Genet. </span>2003;<span class="ref-vol">11</span>:808–11.</span> [<a href="/pubmed/14512972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14512972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.maruyama.2012.2329">Maruyama S, Saito Y, Nakagawa E, Saito T, Komaki H, Sugai K, Sasaki M, Kumada S, Saito Y, Tanaka H, Minami N, Goto Y. Importance of CAG repeat length in childhood-onset dentatorubral-pallidoluysian atrophy. <span><span class="ref-journal">J Neurol. </span>2012;<span class="ref-vol">259</span>:2329–34.</span> [<a href="/pubmed/22527233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22527233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.mori.2012a.134">Mori F, Tanji K, Odagiri S, Toyoshima Y, Yoshida M, Kakita A, Takahashi H, Wakabayashi K. Autophagy-related proteins (p62, NBR1 and LC3) in intranuclear inclusions in neurodegenerative diseases. <span><span class="ref-journal">Neurosci Lett. </span>2012a;<span class="ref-vol">522</span>:134–8.</span> [<a href="/pubmed/22728060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22728060</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.mori.2012b.747">Mori F, Tanji K, Toyoshima Y, Yoshida M, Kakita A, Takahashi H, Wakabayashi K. Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease. <span><span class="ref-journal">Acta Neuropathol. </span>2012b;<span class="ref-vol">123</span>:747–9.</span> [<a href="/pubmed/22318854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22318854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.mu_oz.2004.946">Mu&#x000f1;oz E, Campdelacreu J, Ferrer I, Rey MJ, Cardozo A, G&#x000f3;mez B, Tolosa E. Severe cerebral white matter involvement in a case of dentatorubropallidoluysian atrophy studied at autopsy. <span><span class="ref-journal">Arch Neurol. </span>2004;<span class="ref-vol">61</span>:946–9.</span> [<a href="/pubmed/15210537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15210537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.nagafuchi.1994.14">Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, Takeda T, Tadokoro K, Kondo I, Murayama N, Tanaka Y, Kikushima H, Umino K, Kurosawa H, Furkawa T, Nihei K, Inoue T, Sana A, Komure O, Takahashi M, Yoshizawa T, Kanazawa I, Yamada M. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. <span><span class="ref-journal">Nat Genet. </span>1994;<span class="ref-vol">6</span>:14–8.</span> [<a href="/pubmed/8136826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8136826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.naito.1982.798">Naito H, Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. <span><span class="ref-journal">Neurology. </span>1982;<span class="ref-vol">32</span>:798–807.</span> [<a href="/pubmed/6808417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6808417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.nucifora.2003.13047">Nucifora FC Jr, Ellerby LM, Wellington CL, Wood JD, Herring WJ, Sawa A, Hayden MR, Dawson VL, Dawson TM, Ross CA. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:13047–55.</span> [<a href="/pubmed/12464607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12464607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.nucifora.2001.2423">Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. <span><span class="ref-journal">Science. </span>2001;<span class="ref-vol">291</span>:2423–8.</span> [<a href="/pubmed/11264541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11264541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.paradisi.2016.215">Paradisi I, Ikonomu V, Arias S. Spinocerebellar ataxias in Venezuela: genetic epidemiology and their most likely ethnic descent. <span><span class="ref-journal">J Hum Genet. </span>2016;<span class="ref-vol">61</span>:215–22.</span> [<a href="/pubmed/26538302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26538302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.romano.2015.985">Romano S, Coarelli G, Marcotulli C, Leonardi L, Piccolo F, Spadaro M, Frontali M, Ferraldeschi M, Vulpiani MC, Ponzelli F, Salvetti M, Orzi F, Petrucci A, Vanacore N, Casali C, Ristori G. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. <span><span class="ref-journal">Lancet Neurol. </span>2015;<span class="ref-vol">14</span>:985–91.</span> [<a href="/pubmed/26321318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26321318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.sakai.2006.2353">Sakai K, Yamada M, Sato T, Yamada M, Tsuji S, Takahashi H. Neuronal atrophy and synaptic alteration in a mouse model of dentatorubral-pallidoluysian atrophy. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:2353–62.</span> [<a href="/pubmed/16891319" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16891319</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.sarma.2016.467">Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: challenges and solutions. <span><span class="ref-journal">Neuropsychiatr Dis Treat. </span>2016;<span class="ref-vol">12</span>:467–85.</span> [<a href="/pmc/articles/PMC4771397/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4771397</span></a>] [<a href="/pubmed/26966367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26966367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.sato.1999a.997">Sato A, Shimohata T, Koide R, Takano H, Sato T, Oyake M, Igarashi S, Tanaka K, Inuzuka T, Nawa H, Tsuji S. Adenovirus-mediated expression of mutant DRPLA proteins with expanded polyglutamine stretches in neuronally differentiated PC12 cells. Preferential intranuclear aggregate formation and apoptosis. <span><span class="ref-journal">Hum Mol Genet. </span>1999a;<span class="ref-vol">8</span>:997–1006.</span> [<a href="/pubmed/10332031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10332031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.sato.1995.1934">Sato K, Kashihara K, Okada S, Ikeuchi T, Tsuji S, Shomori T, Morimoto K, Hayabara T. Does homozygosity advance the onset of dentatorubral-pallidoluysian atrophy? <span><span class="ref-journal">Neurology. </span>1995;<span class="ref-vol">45</span>:1934–6.</span> [<a href="/pubmed/7477999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7477999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.sato.1999b.99">Sato T, Oyake M, Nakamura K, Nakao K, Fukusima Y, Onodera O, Igarashi S, Takano H, Kikugawa K, Ishida Y, Shimohata T, Koide R, Ikeuchi T, Tanaka H, Futamura N, Matsumura R, Takayanagi T, Tanaka F, Sobue G, Komure O, Takahashi M, Sano A, Ichikawa Y, Goto J, Kanazawa I, Katsuki M, Shoji T. Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients. <span><span class="ref-journal">Hum Mol Genet. </span>1999b;<span class="ref-vol">8</span>:99–106.</span> [<a href="/pubmed/9887337" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9887337</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.sato.2009.723">Sato T, Miura M, Yamada M, Yoshida T, Wood JD, Yazawa I, Masuda M, Suzuki S, Shin R-M, Yau H-J, Liu F-C, Shimohata T, Onodera O, Ross CA, Katsuki M, Takahashi H, Kano M, Aosaki T, Tsuji S. Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice. <span><span class="ref-journal">Hum. Mol. Genet. </span>2009;<span class="ref-vol">18</span>:723–36.</span> [<a href="/pmc/articles/PMC2638829/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2638829</span></a>] [<a href="/pubmed/19039037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19039037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.scalco.2012.471">Scalco RS, Vieira MC, da Cunha Filho EV, Lago EG, da Silva IG, Becker J. Amyotrophic lateral sclerosis and riluzole use during pregnancy: a case report. <span><span class="ref-journal">Amyotroph Lateral Scler. </span>2012;<span class="ref-vol">13</span>:471–2.</span> [<a href="/pubmed/22670879" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22670879</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.shen.2007.5037">Shen Y, Lee G, Choe Y, Zoltewicz JS, Peterson AS. Functional architecture of atrophins. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>:5037–44.</span> [<a href="/pubmed/17150957" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17150957</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.shimohata.2005.654">Shimohata M, Shimohata T, Igarashi S, Naruse S, Tsuji S. Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches--augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases. <span><span class="ref-journal">J Neurochem. </span>2005;<span class="ref-vol">93</span>:654–63.</span> [<a href="/pubmed/15836624" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15836624</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.shimohata.2000.29">Shimohata T, Nakajima T, Yamada M, Uchida C, Onodera O, Naruse S, Kimura T, Koide R, Nozaki K, Sano Y, Ishiguro H, Sakoe K, Ooshima T, Sato A, Ikeuchi T, Oyake M, Sato T, Aoyagi Y, Hozumi I, Nagatsu T, Takiyama Y, Nishizawa M, Goto J, Kanazawa I, Davidson I, Tanese N, Takahashi H, Tsuji S. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">26</span>:29–36.</span> [<a href="/pubmed/10973244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10973244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.shimohata.2002.215">Shimohata T, Sato A, Burke JR, Strittmatter WJ, Tsuji S, Onodera O. Expanded polyglutamine stretches form an 'aggresome'. <span><span class="ref-journal">Neurosci Lett. </span>2002;<span class="ref-vol">323</span>:215–8.</span> [<a href="/pubmed/11959423" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11959423</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.shimojo.2001.277">Shimojo Y, Osawa Y, Fukumizu M, Hanaoka S, Tanaka H, Ogata F, Sasaki M, Sugai K. Severe infantile dentatorubral pallidoluysian atrophy with extreme expansion of CAG repeats. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">56</span>:277–8.</span> [<a href="/pubmed/11160976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11160976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.sone.2016.121">Sone D, Sato N, Yokoyama K, Sumida K, Kanai M, Imabayashi E, Saito Y, Matsuda H. Striatal glucose hypometabolism in preadolescent-onset dentatorubral-pallidoluysian atrophy. <span><span class="ref-journal">J Neurol Sci. </span>2016;<span class="ref-vol">360</span>:121–4.</span> [<a href="/pubmed/26723987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26723987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.suzuki.2013.277">Suzuki K, Sato T, Yamada M, Takahashi H, Tsuji S. DRPLA: recent advances in research using transgenic mouse models. <span><span class="ref-journal">Methods Mol Biol. </span>2013;<span class="ref-vol">1010</span>:277–92.</span> [<a href="/pubmed/23754232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23754232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.suzuki.2012.336">Suzuki K, Zhou J, Sato T, Takao K, Miyagawa T, Oyake M, Yamada M, Takahashi H, Takahashi Y, Goto J, Tsuji S. DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles. <span><span class="ref-journal">Neurobiol Dis. </span>2012;<span class="ref-vol">46</span>:336–50.</span> [<a href="/pubmed/22342974" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22342974</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.takano.1998.1060">Takano H, Cancel G, Ikeuchi T, Lorenzetti D, Mawad R, Stevanin G, Didierjean O, Durr A, Oyake M, Shimohata T, Sasaki R, Koide R, Igarashi S, Hayashi S, Takiyama Y, Nishizawa M, Tanaka H, Zoghbi H, Brice A, Tsuji S. Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:1060–6.</span> [<a href="/pmc/articles/PMC1377499/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377499</span></a>] [<a href="/pubmed/9758625" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9758625</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.takayama.2002.902">Takayama N, Iwase Y, Sakio H. Anesthetic management of a patient with dentato-rubro-pallido-luysian atrophy. <span><span class="ref-journal">Masui. </span>2002;<span class="ref-vol">51</span>:902–3.</span> [<a href="/pubmed/12229143" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12229143</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.tsuji.2008.189">Tsuji S, Onodera O, Goto J, Nishizawa M., Study Group on Ataxic Diseases.  Sporadic ataxias in Japan--a population-based epidemiological study. <span><span class="ref-journal">Cerebellum. </span>2008;<span class="ref-vol">7</span>:189–97.</span> [<a href="/pubmed/18418674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18418674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.tsuji.2012.587">Tsuji S. Dentatorubral-pallidoluysian atrophy. <span><span class="ref-journal">Handb Clin Neurol. </span>2012;<span class="ref-vol">103</span>:587–94.</span> [<a href="/pubmed/21827919" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21827919</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.van_de_warrenburg.2014.552">van de Warrenburg BP, van Gaalen J, Boesch S, Burgunder JM, Durr A, Giunti P, Klockgether T, Mariotti C, Pandolfo M, Riess O. EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. <span><span class="ref-journal">Eur J Neurol. </span>2014;<span class="ref-vol">21</span>:552–62.</span> [<a href="/pubmed/24418350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24418350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.veneziano.2014.153">Veneziano L, Mantuano E, Catalli C, Gellera C, Durr A, Romano S, Spadaro M, Frontali M, Novelletto A. A shared haplotype for dentatorubropallidoluysian atrophy (DRPLA) in Italian families testifies of the recent introduction of the mutation. <span><span class="ref-journal">J Hum Genet. </span>2014;<span class="ref-vol">59</span>:153–7.</span> [<a href="/pubmed/24401908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24401908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.vinton.2005.201">Vinton A, Fahey MC, O'Brien TJ, Shaw J, Storey E, Gardner RJ, Mitchell PJ, Du Sart D, King JO. Dentatorubral-pallidoluysian atrophy in three generations, with clinical courses from nearly asymptomatic elderly to severe juvenile, in an Australian family of Macedonian descent. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">136</span>:201–4.</span> [<a href="/pubmed/15948186" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15948186</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.wardle.2009.1636">Wardle M, Morris HR, Robertson NP. Clinical and genetic characteristics of non-Asian dentatorubral-pallidoluysian atrophy: A systematic review. <span><span class="ref-journal">Mov Disord. </span>2009;<span class="ref-vol">24</span>:1636–40.</span> [<a href="/pubmed/19514013" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19514013</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.warner.1996.1022">Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, Brock DJ. A general method for the detection of large CAG repeat expansions by fluorescent PCR. <span><span class="ref-journal">J Med Genet. </span>1996;<span class="ref-vol">33</span>:1022–6.</span> [<a href="/pmc/articles/PMC1050815/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050815</span></a>] [<a href="/pubmed/9004136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9004136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.wood.2000.939">Wood JD, Nucifora FC, Duan K, Zhang C, Wang J, Kim Y, Schilling G, Sacchi N, Liu JM, Ross CA. Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, Interacts with ETO/MTG8 in the nuclear matrix and represses transcription. <span><span class="ref-journal">J Cell Biol. </span>2000;<span class="ref-vol">150</span>:939–48.</span> [<a href="/pmc/articles/PMC2175251/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2175251</span></a>] [<a href="/pubmed/10973986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10973986</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.yamada.2000.615">Yamada M, Piao YS, Toyoshima Y, Tsuji S, Takahashi H. Ubiquitinated filamentous inclusions in cerebellar dentate nucleus neurons in dentatorubral-pallidoluysian atrophy contain expanded polyglutamine stretches. <span><span class="ref-journal">Acta Neuropathol (Berl). </span>2000;<span class="ref-vol">99</span>:615–8.</span> [<a href="/pubmed/10867794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10867794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.yamada.2002.317">Yamada M, Tsuji S, Takahashi H. Genotype-phenotype correlation in CAG-repeat diseases. <span><span class="ref-journal">Neuropathology. </span>2002;<span class="ref-vol">22</span>:317–22.</span> [<a href="/pubmed/12564773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12564773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.yamada.2001.14">Yamada M, Wood JD, Shimohata T, Hayashi S, Tsuji S, Ross CA, Takahashi H. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:14–23.</span> [<a href="/pubmed/11198291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11198291</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.zhang.2014">Zhang F, Xu D, Yuan L, Sun Y, Xu Z (2014) Epigenetic regulation of Atrophin1 by lysine-specific demethylase 1 is required for cortical progenitor maintenance. Nat Commun. 18;5:5815. [<a href="/pmc/articles/PMC4284801/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4284801</span></a>] [<a href="/pubmed/25519973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25519973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="drpla.REF.zhang.2002.45">Zhang S, Xu L, Lee J, Xu T. Drosophila atrophin homolog functions as a transcriptional corepressor in multiple developmental processes. <span><span class="ref-journal">Cell. </span>2002;<span class="ref-vol">108</span>:45–56.</span> [<a href="/pubmed/11792320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11792320</span></a>]</div></li></ul></div></div><div id="drpla.Chapter_Notes"><h2 id="_drpla_Chapter_Notes_">Chapter Notes</h2><div id="drpla.Author_Notes"><h3>Author Notes</h3><p><b>Ataxia Study Group (ASG)</b></p><p><b>Director:</b>
<a href="mailto:dev@null" data-email="rehtegkcolK samohT rD forP" class="oemail">rehtegkcolK samohT rD forP</a><br /><b>Phone:</b> +49 (0)228-287-15750<br /><b>Fax:</b>+49 (0)228-287-14760<br /><b>Email:</b>
<a href="mailto:dev@null" data-email="ed.nnob-inu@eigoloruen" class="oemail">ed.nnob-inu@eigoloruen</a><br /><a href="http://www.ataxia-study-group.net/html/asg?clps2478_1238824786=1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia-study-group.net</a></p><p>The Ataxia Study Group (ASG) is an international consortium of scientific investigators from academic and research centers who are committed to the cooperative planning, implementation, and performance of clinical trials and other research studies in ataxia disorders. The ASG was founded on the 14 Jan 2008 in Strasbourg (France) and has the legal form of a European Economic Interest Grouping (EEIG). It is open to clinicians and scientists who are experienced in management of ataxia patients, who have performed or participated in clinical studies of ataxia patients, or who have made other important contributions to the field of ataxia research.</p></div><div id="drpla.Author_History"><h3>Author History</h3><p>Marina Frontali, MD (2016-present)<br />Shoji Tsuji, MD, PhD; University of Tokyo Graduate School of Medicine (1999-2016)<br />Liana Veneziano, PhD (2016-present)</p></div><div id="drpla.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>9 June 2016 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 June 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 December 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 June 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 May 2002 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 August 1999 (pb) Review posted live</div></li><li class="half_rhythm"><div>15 February 1999 (st) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1491</span><span class="label">PMID: <a href="/pubmed/20301664" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301664</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/dnmt1-ddsn/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/dyrk1a-id/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1491&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1491/?report=reader">PubReader</a></li><li><a href="/books/NBK1491/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1491" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1491" style="display:none" title="Cite this Page"><div class="bk_tt">Veneziano L, Frontali M. DRPLA. 1999 Aug 6 [Updated 2016 Jun 9]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1491/pdf/Bookshelf_NBK1491.pdf">PDF version of this page</a> (454K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#drpla.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#drpla.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#drpla.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#drpla.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#drpla.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#drpla.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#drpla.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#drpla.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#drpla.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#drpla.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#drpla.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1822[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATN1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1491+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1492468" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1492468" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1492468" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1492468" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/7774119" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Molecular basis of heterogeneities of clinical presentation of dentatorubral pallidoluysian atrophy (DRPLA)].</a><span class="source">[Rinsho Shinkeigaku. 1994]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Molecular basis of heterogeneities of clinical presentation of dentatorubral pallidoluysian atrophy (DRPLA)].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tsuji S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rinsho Shinkeigaku. 1994 Dec; 34(12):1227-9. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/7778850" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat.</a><span class="source">[Ann Neurol. 1995]</span><div class="brieflinkpop offscreen_noflow">Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ikeuchi T, Koide R, Tanaka H, Onodera O, Igarashi S, Takahashi H, Kondo R, Ishikawa A, Tomoda A, Miike T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Neurol. 1995 Jun; 37(6):769-75. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/7824105" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation.</a><span class="source">[Neurology. 1995]</span><div class="brieflinkpop offscreen_noflow">DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Komure O, Sano A, Nishino N, Yamauchi N, Ueno S, Kondoh K, Sano N, Takahashi M, Murayama N, Kondo I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurology. 1995 Jan; 45(1):143-9. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10434307" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Molecular pathology of dentatorubral-pallidoluysian atrophy.</a><span class="source">[Philos Trans R Soc Lond B Biol...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Molecular pathology of dentatorubral-pallidoluysian atrophy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kanazawa I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29; 354(1386):1069-74. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/9933295" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease.</a><span class="source">[Neurogenetics. 1998]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kanazawa I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurogenetics. 1998 Dec; 2(1):1-17. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301664" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301664" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040cd075f66d18aa8d576e">DRPLA - GeneReviews®</a><div class="ralinkpop offscreen_noflow">DRPLA - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:28:48-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D0441E03FA2110000000006ED027C&amp;ncbi_session=CE8D0441E040CCF1_1773SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1491%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1491&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1491/&amp;ncbi_pagename=DRPLA - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D0441E040CCF1_1773SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>